Artwork
iconShare
 
Manage episode 513815944 series 2740117
Content provided by MasterMedFacts LLC and RR Baliga MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MasterMedFacts LLC and RR Baliga MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

🚨 Real-World vs RCT? Only 1 in 3 patients with AMI-related cardiogenic shock in Japan met the šŸ”¬ DanGer trial criteria for Impella use. The J-PVAD registry (šŸ‡ÆšŸ‡µ, n=3975) reveals a stark āš–ļø reality: eligibility matters, and survival varies!

šŸ«€ Time to align practice with precision.

šŸ“– Read the full European Heart Journal study for clinical pearls and caveats. #Impella #CardiogenicShock #DanGer #JPVAD #EHJ #MCS #RCTvsRealWorld

  continue reading

731 episodes